10-K: Inflection Point IV Nears Merlin Labs Merger Completion

Inflection Point Acquisition Corp. IV's shareholders approved its business combination with Merlin Labs, Inc., an AI-driven aerospace company, with closing expected by March 16, 2026.

Summary

• Inflection Point Acquisition Corp. IV (the Company), a blank check company, was incorporated on June 24, 2024, for the purpose of effecting a business combination.
• The Company consummated its Initial Public Offering (IPO) on November 4, 2024, raising gross proceeds of $250,000,000 by selling 25,000,000 units at $10.00 per unit.
• Simultaneously with the IPO, the Sponsor purchased 425,000 Private Placement Units for $4,250,000.
• On August 13, 2025, the Company entered into a Business Combination Agreement with Merlin Labs, Inc., an AI-driven aerospace company, which will result in Merlin becoming a wholly-owned subsidiary and the Company changing its name to Merlin, Inc.
• Shareholders approved the Proposed Business Combination at an Extraordinary General Meeting (EGM) held on March 12, 2026, with closing anticipated on March 16, 2026.
• Public Shareholders holding 22,550,551 Public Shares, representing approximately 90.3% of the outstanding Public Shares, exercised their redemption rights in connection with the Proposed Business Combination.
• The aggregate consideration for Merlin Equity Holders is $800,000,000 in New Merlin Common Stock.
• Merlin issued approximately $88.9 million in Pre-Funded Convertible Notes and Warrants and secured $120 million in Series A Preferred Stock investments from PIPE investors.
• The Company reported a net income of $6,008,347 for the year ended December 31, 2025, primarily from interest earned on investments in the Trust Account.
• As of December 31, 2025, the Company had a working capital deficit of $2,416,322 and $703,596 in unrestricted cash outside the Trust Account.
• The Company's liquidity condition and mandatory liquidation date of November 4, 2026, if the business combination is not completed, raise substantial doubt about its ability to continue as a going concern.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a challenging but progressing situation. While the business combination with Merlin Labs has been approved, the extremely high redemption rate and the explicit 'going concern' warning indicate significant financial hurdles and investor skepticism that temper the positive news of the merger's approval.

Positives

• Shareholders approved the Proposed Business Combination with Merlin Labs, Inc. on March 12, 2026, paving the way for the merger's completion.
• Nasdaq has approved the listing of New Merlin Common Stock under the symbol MRLN following the consummation of the Proposed Business Combination.
• Merlin Labs, Inc. is described as a leader in developing aircraft-agnostic autonomy for national security applications and is on pace to be the first to certify an AI skill on an aircraft.
• The Company generated a net income of $6,008,347 for the year ended December 31, 2025, primarily from interest income on the Trust Account.
• The Sponsor has agreed to waive its anti-dilution rights with respect to the conversion rate of Class B Ordinary Shares into Class A Ordinary Shares in connection with the Proposed Business Combination.
• The board of directors determined that the value of Merlin exceeded the Nasdaq 80% fair market value test for business combinations.

Negatives

• A high redemption rate of approximately 90.3% (22,550,551 Public Shares) significantly reduced the cash available to the combined company from the Trust Account.
• The Company reported a working capital deficit of $2,416,322 as of December 31, 2025, indicating liquidity challenges.
• The Company's liquidity condition and the mandatory liquidation date of November 4, 2026, if the business combination is not completed, raise substantial doubt about its ability to continue as a going concern.
• The deferred underwriting compensation of $8,750,000 is not adjusted for redemptions, which will result in increased dilution for non-redeeming shareholders.
• The Company is a blank check company with no operating history or revenues to date, relying entirely on the success of the business combination.
• The potential for significant dilution for existing shareholders exists due to new share issuances in PIPE transactions and the conversion of rights.

Risks

• Public Shareholders' opportunity to affect investment decisions regarding a potential Business Combination may be limited to the exercise of their right to redeem their Public Shares for cash.
• High redemption rates may make the Company's financial condition unattractive to potential business combination targets, making it difficult to enter into an initial business combination or meet minimum cash conditions.
• The deferred underwriting compensation is not adjusted for redemptions, which may further dilute the investment of non-redeeming shareholders.
• Failure to complete the initial business combination within the completion window (November 4, 2026) would result in liquidation, rendering Public Rights worthless.
• The Sponsor, directors, executive officers, and their affiliates may elect to purchase Public Shares or Public Rights, which could influence a vote on a proposed business combination and reduce the public float.
• Limited resources and significant competition for business combination opportunities may make it more difficult to complete an initial business combination.
• The Company may depend on loans from the Sponsor or management team to complete the Business Combination if net proceeds outside the Trust Account are insufficient.
• Third-party claims against the Company could reduce the proceeds held in the Trust Account, leading to a per-share redemption amount less than $10.00.
• Directors may decide not to enforce the indemnification obligations of the Sponsor, further reducing funds available for Public Shareholders.
• Shareholders may be held liable for claims by third parties against the Company to the extent of distributions received upon redemption of their shares.
• Changes in laws or regulations, or a failure to comply, may adversely affect the Company's business and ability to complete an initial business combination.
• Potential conflicts of interest may arise from relationships with entities affiliated with the Sponsor, officers, or directors.
• The absence of a specified maximum redemption threshold may allow the Company to complete an initial business combination even if a substantial majority of shareholders do not agree.
• An investment in the Company's securities may result in uncertain U.S. federal income tax consequences.
• Key personnel may negotiate employment or consulting agreements with a target business, potentially creating conflicts of interest.
• Shareholders will not have any rights or interests in funds from the Trust Account, except under certain limited circumstances, forcing them to sell Public Shares or Public Rights, potentially at a loss, to liquidate their investment.
• The Company is a blank check company with no operating history or revenues, providing no basis to evaluate its ability to achieve its business objective.
• Past performance by the management team, advisors, and their affiliates may not be indicative of future performance of an investment in the Company.
• Due to incorporation under Cayman Islands law, investors may face difficulties in protecting their interests and enforcing rights through U.S. Federal courts.
• A U.S. federal excise tax could be imposed on the Company in connection with any redemptions of Class A Ordinary Shares after or in connection with an initial business combination involving a U.S. company, if the Company domesticates to Delaware.
• The Company may be a Passive Foreign Investment Company (PFIC), which could result in adverse U.S. federal income tax consequences to U.S. investors.
• After the initial business combination, a majority of directors and officers may live outside the United States and all assets may be located outside the United States, making enforcement of federal securities laws or other legal rights difficult.
• Taking advantage of certain exemptions from disclosure requirements as an emerging growth company and smaller reporting company could make the Company's securities less attractive to investors and comparison with other public companies more difficult.
• Provisions in the Company's Articles may inhibit a takeover, potentially limiting the price investors might be willing to pay for Class A Ordinary Shares and entrenching management.
• Cyber incidents or attacks directed at the Company or its third-party digital technologies could result in information theft, data corruption, operational disruption, and/or financial loss.
• The Company's Articles designate the courts of the Cayman Islands as the exclusive forum for certain disputes, which could limit shareholders' ability to obtain a favorable judicial forum.
• Recent increases in inflation could make it more difficult for the Company to complete its initial business combination.

Future Outlook

The Company expects to consummate its business combination with Merlin Labs, Inc. on March 16, 2026, after which it will change its name to Merlin, Inc. and its common stock will be listed on Nasdaq under MRLN. Merlin's management team is anticipated to remain with the combined entity. The Company expects to incur increased expenses as a public company and acknowledges the need for potential additional financing to fund operations or growth of the target business, especially given its current working capital deficit and the high redemption rate.

Management Comments

• Our management team has extensive experience in identifying and executing strategic investments globally and has done so successfully in a number of sectors, including the healthcare or healthcare-related industries sector.
• We believe that our success depends on the continued service of our officers and directors, at least until we have completed our initial business combination.
• We intend to closely scrutinize any individuals we engage after our initial business combination, we cannot assure you that our assessment of these individuals will prove to be correct.
• We do not believe that any such potential conflicts would materially affect our ability to complete our initial business combination.

Industry Context

StockSavvy.ai notes that Inflection Point Acquisition Corp. IV, as a Special Purpose Acquisition Company (SPAC), is executing its strategy to identify and merge with a technology-driven company. The proposed business combination with Merlin Labs, an AI-driven aerospace firm, aligns with the Company's stated focus on sectors undergoing digital transformation, particularly in artificial intelligence and advanced connectivity. The high redemption rate of 90.3% observed in this transaction is a notable trend in the current SPAC market, reflecting heightened investor scrutiny and a challenging environment for de-SPAC transactions, which can significantly impact the capital available to the combined entity post-merger.

Comparison to Industry Standards

• The filing states that Merlin is 'on pace to be the first to certify an AI skill on an aircraft,' positioning it as a potential leader in a nascent but high-growth segment of the aerospace industry, though no specific comparable companies or projects are detailed.
• StockSavvy.ai notes that the 90.3% redemption rate is significantly higher than historical SPAC averages, which typically ranged from 50-70% in more favorable market conditions, indicating strong investor skepticism or alternative investment opportunities. This high redemption rate could be compared to other recent de-SPAC transactions in the aerospace or AI sectors, which have also seen elevated redemptions, but the filing does not provide specific names.

Management Changes

Corporate Governance

Legal Proceedings

• To the knowledge of management, there is no material litigation currently pending or contemplated against the Company, any of its officers or directors in their capacity as such, or against any of its property.

Related Party Transactions

• The Sponsor (Bleichroeder Sponsor 1 LLC) made an initial capital contribution of $25,000 for Founder Shares and later received additional Founder Shares, totaling 8,333,333 Founder Shares after forfeiture.
• The Sponsor purchased 425,000 Private Placement Units for $4,250,000 simultaneously with the IPO.
• The Sponsor and officers/directors have agreed to waive their redemption rights and vote their shares in favor of the initial business combination.
• The Sponsor has agreed to be liable to the Company if third-party claims reduce the Trust Account funds below $10.00 per Public Share, though the Company notes the Sponsor's only assets are its securities.
• Inflection Point Fund I LP, an affiliate of a member of the Company's management, indirectly purchased Private Placement Units and holds an indirect interest in 5,266,667 Founder Shares through its non-managing membership interests in the Sponsor.
• The Sponsor transferred Class A Units (representing indirect interests in Founder Shares) to individuals on August 12, 2025, September 22, 2025, and October 1, 2025, resulting in recorded compensation expense of $670,000 for the October 1, 2025 transfer.
• Michael Blitzer, the Company's Chief Executive Officer, is expected to serve as a director of New Merlin after the consummation of the Proposed Business Combination.
• Andrew Gundlach, the Company's Chairman, serves as President and Co-Chief Executive Officer at Bleichroeder and heads Goldiron, both registered investment advisors, and holds other board positions.
• Robert Folino, the Company's Chief Financial Officer, is Chief Operating Officer and Head of Trading of Bleichroeder.
• Kevin Shannon, the Company's Chief Operating Officer, is a founder and partner of Inflection Point Asset Management and serves as Chief Operating Officer for other Inflection Point Acquisition Corps.
• Joseph Samuels and Antoine Theysset, directors, also serve as officers and/or board members for other entities, including other investment firms and technology companies.
• Kathy Savitt, a director, serves as a General Partner at Perch Partners, LLC, and holds other public and private board roles.

Stakeholder Impact

• **Shareholders:** Public shareholders who redeemed their shares received cash. Non-redeeming public shareholders will become shareholders of New Merlin, with their investment value tied to Merlin's future performance, subject to potential dilution from PIPE investments, convertible notes, and warrants.
• **Sponsor/Management:** Their Founder Shares and Private Placement Units will convert into New Merlin stock, providing a significant return if the combined company performs well, but they risk losing their investment if the merger fails. They have waived anti-dilution rights for the Class B shares.
• **Merlin Equity Holders:** Will receive $800,000,000 in New Merlin Common Stock, transitioning their private equity holdings into publicly traded shares.
• **Pre-Funded Investors:** Will receive Series A Preferred Stock and New Merlin Series A Warrants, providing a structured investment in the combined entity.
• **Underwriters:** Will receive deferred underwriting fees upon completion of the business combination, though some payments were deferred, impacting their cash flow timing.
• **Employees (of Merlin):** Merlin's management team is expected to remain, ensuring continuity. The transaction proposals include an equity incentive plan and employee stock purchase plan for New Merlin, potentially benefiting employees.

Next Steps

• Consummation of the Proposed Business Combination with Merlin Labs, Inc. on March 16, 2026.
• The Company will change its name to Merlin, Inc. upon closing of the Business Combination.
• New Merlin Common Stock will be listed on the Nasdaq Stock Market LLC under the symbol MRLN.
• Commencement of deferred underwriting payments to the underwriters on September 1, 2026.

Key Dates

Recommendation

The approval of the business combination with Merlin Labs is a critical milestone for the SPAC, moving it closer to becoming an operating company. However, the exceptionally high redemption rate of 90.3% by public shareholders significantly reduces the cash available to the combined entity, creating substantial financial uncertainty. The explicit 'going concern' warning further highlights the liquidity challenges. While Merlin's business in AI-driven aerospace is promising, the post-merger capital structure and the ability to execute growth plans with reduced cash warrant a cautious 'hold' stance for existing investors, rather than a 'buy' given the risks, or a 'sell' given the merger is proceeding.

Keywords

SPAC, Business Combination, Merger, Merlin Labs, AI, Aerospace, Autonomy, SEC Filing, 10-K, Inflection Point Acquisition Corp. IV, De-SPAC, Nasdaq, PIPE, Redemption, Corporate Governance, Risk Factors, Financial Reporting, Cayman Islands, Delaware Domestication